Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2019-08-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2019年半年度财务报告
Regulatory Filings
2019-08-21 Chinese
2015年公司债券2019年付息公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the interest payment for a corporate bond issued by 华邦生命健康股份有限公司. It details the bond's basic information, interest payment schedule, interest rate adjustments, tax implications, and payment procedures. The document is dated August 6, 2019, and specifies the interest payment date as August 14, 2019. It does not contain financial statements or comprehensive financial data but serves as a formal notice to bondholders about the upcoming interest payment. The document length is 3781 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of a Capital/Financing Update (CAP), as it relates to bond interest payment and financing details.
2019-08-06 Chinese
关于子公司获得《药品注册批件》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding its subsidiaries obtaining drug registration approvals from the National Medical Products Administration. It details the drug names, specifications, approvals, and potential impact on the company. The document is relatively short (1617 characters) and serves as a formal announcement of regulatory approvals rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not a report publication announcement since it does not mention an attached report or provide a link to a report. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about approvals and does not fit other specific categories like earnings, management changes, or capital updates.
2019-07-15 Chinese
2018年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an "权益分派实施公告" which translates to "Implementation Announcement of Equity Distribution" for the 2018 fiscal year. It details the dividend distribution plan approved at the 2018 Annual General Meeting, including dividend amounts, record dates, and payment methods. The document is relatively short (2164 characters) and primarily announces the implementation of the dividend distribution plan rather than presenting a full financial report or detailed analysis. It references the shareholder meeting resolutions and dividend details but does not contain comprehensive financial statements or management discussion. Therefore, this document is best classified as a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2019-06-28 Chinese
关于控股子公司签署《委托实验合同》暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding a related-party transaction involving a controlling subsidiary signing an entrusted experiment contract with an affiliated company. It includes comprehensive information about the transaction, the parties involved, contract terms, financial data of the related party, and the strategic purpose and risks of the transaction. There is no indication that this is a financial report, earnings release, or regulatory certification. The content focuses on disclosure of a related-party transaction, which is typical for regulatory filings related to corporate governance and compliance with stock exchange rules. The document is not a report publication announcement since it contains substantive details rather than just a notice of report availability. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-06-21 Chinese
关于对深圳证券交易所2018年年报问询函的回复公告
Annual Report Classification · 95% confidence The document is a detailed reply to an inquiry letter from the Shenzhen Stock Exchange regarding the company's 2018 annual report. It contains extensive financial data, explanations of accounting policies, business operations, and detailed financial analysis for the fiscal year 2018. The content includes revenue, profit, cash flow analysis, goodwill impairment, and other financial disclosures typical of a comprehensive annual report. The document is lengthy (15,000 characters) and contains substantive financial data and management explanations, indicating it is the actual annual report or a detailed part of it, not merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2018
2019-06-13 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.